{"id":7619,"date":"2024-04-09T16:54:51","date_gmt":"2024-04-09T21:54:51","guid":{"rendered":"https:\/\/fifarma.org\/?post_type=publicaciones&#038;p=7619"},"modified":"2024-04-22T16:57:21","modified_gmt":"2024-04-22T21:57:21","slug":"carta-abierta-de-la-industria-biofarmaceutica-a-los-ministros-desalud-del-g20-en-apoyo-al-avance-de-la-agenda-de-salud-delg20","status":"publish","type":"publicaciones","link":"https:\/\/fifarma.org\/pt\/publicacoes\/carta-abierta-de-la-industria-biofarmaceutica-a-los-ministros-desalud-del-g20-en-apoyo-al-avance-de-la-agenda-de-salud-delg20\/","title":{"rendered":"Carta abierta de la industria biofarmac\u00e9utica a los Ministros deSalud del G20 en apoyo al avance de la Agenda de Salud delG20"},"content":{"rendered":"\n<p class=\"has-small-font-size\">Con las negociaciones en curso en Ginebra y menos de seis a\u00f1os para lograr los Objetivos de Desarrollo Sostenible (ODS), el foro del G20 sirve como una plataforma clave para promover soluciones constructivas, coordinadas y colaborativas.<br><a href=\"https:\/\/fifarma.org\/wp-content\/uploads\/2024\/04\/G20-Brazil-Biopharmaceutical-Industry-Letter_April-2024_Espanol.pdf\">Visualizar<\/a><\/p>\n\n    <div class=\"xs_social_share_widget xs_share_url after_content \t\tmain_content  wslu-style-1 wslu-share-box-shaped wslu-fill-colored wslu-none wslu-share-horizontal wslu-theme-font-no wslu-main_content\">\n\n\t\t\n        <ul>\n\t\t\t        <\/ul>\n    <\/div> \n","protected":false},"author":24,"parent":0,"template":"","ano":[88],"idioma":[31],"etiquetas-publicacion":[85],"categoria-publicacion":[36],"class_list":["post-7619","publicaciones","type-publicaciones","status-publish","hentry","ano-88","idioma-espanol","etiquetas-publicacion-farmacovigilancia","categoria-publicacion-position-paper"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.7 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Carta abierta de la industria biofarmac\u00e9utica a los Ministros deSalud del G20 en apoyo al avance de la Agenda de Salud delG20 - FIFARMA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fifarma.org\/pt\/publicacoes\/carta-abierta-de-la-industria-biofarmaceutica-a-los-ministros-desalud-del-g20-en-apoyo-al-avance-de-la-agenda-de-salud-delg20\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Carta abierta de la industria biofarmac\u00e9utica a los Ministros deSalud del G20 en apoyo al avance de la Agenda de Salud delG20\" \/>\n<meta property=\"og:description\" content=\"Con las negociaciones en curso en Ginebra y menos de seis a\u00f1os para lograr los Objetivos de Desarrollo Sostenible (ODS), el foro del G20 sirve como una plataforma clave para promover soluciones constructivas, coordinadas y colaborativas.Visualizar\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fifarma.org\/pt\/publicacoes\/carta-abierta-de-la-industria-biofarmaceutica-a-los-ministros-desalud-del-g20-en-apoyo-al-avance-de-la-agenda-de-salud-delg20\/\" \/>\n<meta property=\"og:site_name\" content=\"FIFARMA\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-22T21:57:21+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/carta-abierta-de-la-industria-biofarmaceutica-a-los-ministros-desalud-del-g20-en-apoyo-al-avance-de-la-agenda-de-salud-delg20\\\/\",\"url\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/carta-abierta-de-la-industria-biofarmaceutica-a-los-ministros-desalud-del-g20-en-apoyo-al-avance-de-la-agenda-de-salud-delg20\\\/\",\"name\":\"Carta abierta de la industria biofarmac\u00e9utica a los Ministros deSalud del G20 en apoyo al avance de la Agenda de Salud delG20 - FIFARMA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#website\"},\"datePublished\":\"2024-04-09T21:54:51+00:00\",\"dateModified\":\"2024-04-22T21:57:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/carta-abierta-de-la-industria-biofarmaceutica-a-los-ministros-desalud-del-g20-en-apoyo-al-avance-de-la-agenda-de-salud-delg20\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/carta-abierta-de-la-industria-biofarmaceutica-a-los-ministros-desalud-del-g20-en-apoyo-al-avance-de-la-agenda-de-salud-delg20\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/carta-abierta-de-la-industria-biofarmaceutica-a-los-ministros-desalud-del-g20-en-apoyo-al-avance-de-la-agenda-de-salud-delg20\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/fifarma.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Publicaciones\",\"item\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Carta abierta de la industria biofarmac\u00e9utica a los Ministros deSalud del G20 en apoyo al avance de la Agenda de Salud delG20\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#website\",\"url\":\"https:\\\/\\\/fifarma.org\\\/\",\"name\":\"FIFARMA\",\"description\":\"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica\",\"publisher\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fifarma.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\",\"name\":\"Fifarma\",\"alternateName\":\"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica\",\"url\":\"https:\\\/\\\/fifarma.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-fifarma.png\",\"contentUrl\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-fifarma.png\",\"width\":195,\"height\":39,\"caption\":\"Fifarma\"},\"image\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Carta abierta de la industria biofarmac\u00e9utica a los Ministros deSalud del G20 en apoyo al avance de la Agenda de Salud delG20 - FIFARMA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fifarma.org\/pt\/publicacoes\/carta-abierta-de-la-industria-biofarmaceutica-a-los-ministros-desalud-del-g20-en-apoyo-al-avance-de-la-agenda-de-salud-delg20\/","og_locale":"pt_BR","og_type":"article","og_title":"Carta abierta de la industria biofarmac\u00e9utica a los Ministros deSalud del G20 en apoyo al avance de la Agenda de Salud delG20","og_description":"Con las negociaciones en curso en Ginebra y menos de seis a\u00f1os para lograr los Objetivos de Desarrollo Sostenible (ODS), el foro del G20 sirve como una plataforma clave para promover soluciones constructivas, coordinadas y colaborativas.Visualizar","og_url":"https:\/\/fifarma.org\/pt\/publicacoes\/carta-abierta-de-la-industria-biofarmaceutica-a-los-ministros-desalud-del-g20-en-apoyo-al-avance-de-la-agenda-de-salud-delg20\/","og_site_name":"FIFARMA","article_modified_time":"2024-04-22T21:57:21+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. tempo de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fifarma.org\/publicaciones\/carta-abierta-de-la-industria-biofarmaceutica-a-los-ministros-desalud-del-g20-en-apoyo-al-avance-de-la-agenda-de-salud-delg20\/","url":"https:\/\/fifarma.org\/publicaciones\/carta-abierta-de-la-industria-biofarmaceutica-a-los-ministros-desalud-del-g20-en-apoyo-al-avance-de-la-agenda-de-salud-delg20\/","name":"Carta abierta de la industria biofarmac\u00e9utica a los Ministros deSalud del G20 en apoyo al avance de la Agenda de Salud delG20 - FIFARMA","isPartOf":{"@id":"https:\/\/fifarma.org\/#website"},"datePublished":"2024-04-09T21:54:51+00:00","dateModified":"2024-04-22T21:57:21+00:00","breadcrumb":{"@id":"https:\/\/fifarma.org\/publicaciones\/carta-abierta-de-la-industria-biofarmaceutica-a-los-ministros-desalud-del-g20-en-apoyo-al-avance-de-la-agenda-de-salud-delg20\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fifarma.org\/publicaciones\/carta-abierta-de-la-industria-biofarmaceutica-a-los-ministros-desalud-del-g20-en-apoyo-al-avance-de-la-agenda-de-salud-delg20\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fifarma.org\/publicaciones\/carta-abierta-de-la-industria-biofarmaceutica-a-los-ministros-desalud-del-g20-en-apoyo-al-avance-de-la-agenda-de-salud-delg20\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/fifarma.org\/"},{"@type":"ListItem","position":2,"name":"Publicaciones","item":"https:\/\/fifarma.org\/publicaciones\/"},{"@type":"ListItem","position":3,"name":"Carta abierta de la industria biofarmac\u00e9utica a los Ministros deSalud del G20 en apoyo al avance de la Agenda de Salud delG20"}]},{"@type":"WebSite","@id":"https:\/\/fifarma.org\/#website","url":"https:\/\/fifarma.org\/","name":"FIFARMA","description":"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica","publisher":{"@id":"https:\/\/fifarma.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fifarma.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/fifarma.org\/#organization","name":"Fifarma","alternateName":"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica","url":"https:\/\/fifarma.org\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/fifarma.org\/#\/schema\/logo\/image\/","url":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/logo-fifarma.png","contentUrl":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/logo-fifarma.png","width":195,"height":39,"caption":"Fifarma"},"image":{"@id":"https:\/\/fifarma.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/publicaciones\/7619","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/publicaciones"}],"about":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/types\/publicaciones"}],"author":[{"embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/users\/24"}],"wp:attachment":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/media?parent=7619"}],"wp:term":[{"taxonomy":"ano","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/ano?post=7619"},{"taxonomy":"idioma","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/idioma?post=7619"},{"taxonomy":"etiquetas-publicacion","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/etiquetas-publicacion?post=7619"},{"taxonomy":"categoria-publicacion","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/categoria-publicacion?post=7619"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}